PureTech HealthPRTC
Market Cap: $464M
About: PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
Employees: 90
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
76% more capital invested
Capital invested by funds: $686K [Q1] → $1.21M (+$520K) [Q2]
50% more funds holding
Funds holding: 4 [Q1] → 6 (+2) [Q2]
0.13% more ownership
Funds ownership: 0.01% [Q1] → 0.13% (+0.13%) [Q2]
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Leerink Partners Faisal Khurshid 71% 1-year accuracy 5 / 7 met price target | 132%upside $45 | Outperform Assumed | 9 Sept 2024 |
Financial journalist opinion
Based on 3 articles about PRTC published over the past 30 days